In a joint operation, the United States and India prevented about 500 shipments of illicit and potentially dangerous unapproved prescription drugs and combination medical devices from entering the United States last month, the U.S. Food and Drug Administration (FDA) announced on Feb. 18.
In the FDA’s first joint operation with the government of India to protect consumers from illicit medical products, “Operation Broadsword” targeted packages entering the United States through an international mail facility from Jan. 28 through Jan. 30, the agency said.